Berry Consultants
Berry Consultants is a scientific consulting company specializing in innovative adaptive clinical trial design, analysis, implementation, and software solutions for the pharmaceutical and medical device industry. They focus on transforming clinical research through Bayesian methodologies, platform trials, and software tools to improve drug development and medical research outcomes. The company actively participates in industry conferences, sponsors webinars, and collaborates on platform trial designs, including antibiotic and disease-specific trials, to advance precision medicine and efficient evaluation of treatments.
Industries
Nr. of Employees
small (1-50)
Berry Consultants
Austin, Texas, United States, North America
Products
Clinical trial simulation platform
Simulation engine for designing, comparing, and evaluating fixed and adaptive clinical trial designs, with modules for platform trials and dose-escalation and interfaces for external analysis and visualization tools.
Document template suite for platform trials
Maintained templates for master protocols, intervention-specific appendices, statistical analysis plans, and DMC charters to support development and regulatory submission of platform trials.
FACTS Software
Software solutions that help Biostatisticians rapidly design, compare, and simulate both fixed and adaptive trial designs through powerful, versatile and fast simulation tools.
Adaptive Clinical Trial Design Services
Custom adaptive clinical trial design and simulation services leveraging Bayesian analysis for drugs, biologics, and medical devices.
ADDPLAN
Specialized module for Dose-Finding Designs including MCP-Mod, enabling precision dose optimization with regulatory-backed methodologies.
QUOTES
QUOTES (Quantification and Optimization of Trial Expectations Simulator) helps program development teams estimate the financial impact of trial design decisions.
Clinical trial simulation platform
Simulation engine for designing, comparing, and evaluating fixed and adaptive clinical trial designs, with modules for platform trials and dose-escalation and interfaces for external analysis and visualization tools.
Document template suite for platform trials
Maintained templates for master protocols, intervention-specific appendices, statistical analysis plans, and DMC charters to support development and regulatory submission of platform trials.
FACTS Software
Software solutions that help Biostatisticians rapidly design, compare, and simulate both fixed and adaptive trial designs through powerful, versatile and fast simulation tools.
Adaptive Clinical Trial Design Services
Custom adaptive clinical trial design and simulation services leveraging Bayesian analysis for drugs, biologics, and medical devices.
ADDPLAN
Specialized module for Dose-Finding Designs including MCP-Mod, enabling precision dose optimization with regulatory-backed methodologies.
QUOTES
QUOTES (Quantification and Optimization of Trial Expectations Simulator) helps program development teams estimate the financial impact of trial design decisions.
Services
Statistical and design consulting to develop pre-specified adaptive components, master protocols, and simulation-based operating-characteristics assessments.
Execution of interim and final analyses, operational guidance for adaptive implementations, and interaction with monitoring committees.
Provision, maintenance, and technical support for simulation software used to compare and simulate fixed and adaptive trial designs; includes module updates and integration with external analysis tools.
Provision of master protocol templates, intervention-specific appendices, statistical analysis plan templates, and DMC charter templates to support development and regulatory submissions for platform trials.
Design and operational support for multi-institution consortia and platform trials, including shared-control strategies, multi-domain design elements, and cross-site information-sharing methods.
Consulting focused on platform-trial designs for antibiotics and infectious-disease interventions, including design choices for outbreak settings and shared-control approaches.
Statistical and design consulting to develop pre-specified adaptive components, master protocols, and simulation-based operating-characteristics assessments.
Execution of interim and final analyses, operational guidance for adaptive implementations, and interaction with monitoring committees.
Provision, maintenance, and technical support for simulation software used to compare and simulate fixed and adaptive trial designs; includes module updates and integration with external analysis tools.
Provision of master protocol templates, intervention-specific appendices, statistical analysis plan templates, and DMC charter templates to support development and regulatory submissions for platform trials.
Design and operational support for multi-institution consortia and platform trials, including shared-control strategies, multi-domain design elements, and cross-site information-sharing methods.
Consulting focused on platform-trial designs for antibiotics and infectious-disease interventions, including design choices for outbreak settings and shared-control approaches.
Expertise Areas
- Adaptive clinical trial management
- Platform trial master-protocol design and operations
- Platform trial design for infectious diseases and antibiotics
- Clinical trial simulation and operating-characteristics evaluation
Key Technologies
- Bayesian statistical methods
- Bayesian hierarchical modeling
- Adaptive design methodologies
- Platform master-protocol frameworks
News & Updates
Berry Consultants will sponsor and participate in the Joint Statistical Meetings in Vancouver, showcasing new software FACTS 6.2 and QUOTES, and participating in sessions.
Berry Consultants will sponsor and host an exhibit booth at JSM 2014 in Boston, with team members presenting in various sessions.
Berry Consultants will participate in the ASA Biopharmaceutical Section FDA-Industry Statistics Workshop in Washington D.C., with team members presenting on adaptive trial topics.
Berry Consultants announced the release of FACTS 7.1, with new features for trial simulation and design.
An article emphasizing the importance of optimizing clinical trial designs through multiple therapies, Bayesian thinking, and platform trials.
Discussion on the costs of highly powered trials and the potential for flexible designs to improve efficiency.
Berry Consultants will sponsor and participate in the Joint Statistical Meetings in Vancouver, showcasing new software FACTS 6.2 and QUOTES, and participating in sessions.
Berry Consultants will sponsor and host an exhibit booth at JSM 2014 in Boston, with team members presenting in various sessions.
Berry Consultants will participate in the ASA Biopharmaceutical Section FDA-Industry Statistics Workshop in Washington D.C., with team members presenting on adaptive trial topics.
Berry Consultants announced the release of FACTS 7.1, with new features for trial simulation and design.
An article emphasizing the importance of optimizing clinical trial designs through multiple therapies, Bayesian thinking, and platform trials.
Discussion on the costs of highly powered trials and the potential for flexible designs to improve efficiency.